Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (109) 109
life sciences & biomedicine (100) 100
humans (99) 99
oncology (95) 95
female (88) 88
middle aged (85) 85
aged (78) 78
adult (71) 71
chemotherapy (59) 59
cancer (46) 46
male (43) 43
antineoplastic combined chemotherapy protocols - therapeutic use (41) 41
biological and medical sciences (39) 39
medical sciences (38) 38
tumors (38) 38
aged, 80 and over (35) 35
treatment outcome (35) 35
breast cancer (33) 33
prognosis (29) 29
breast neoplasms - drug therapy (26) 26
research (23) 23
antineoplastic agents (22) 22
antineoplastic combined chemotherapy protocols - adverse effects (22) 22
disease-free survival (22) 22
human (22) 22
ovarian cancer (19) 19
pharmacology. drug treatments (19) 19
priority journal (19) 19
antineoplastic combined chemotherapy protocols (18) 18
colorectal cancer (18) 18
mutation (18) 18
neoplasm staging (18) 18
paclitaxel (18) 18
paclitaxel - administration & dosage (18) 18
survival rate (18) 18
antineoplastic combined chemotherapy protocols - administration & dosage (17) 17
medicine (17) 17
patients (17) 17
survival analysis (16) 16
chemotherapy, adjuvant (15) 15
controlled study (15) 15
genetic aspects (15) 15
gynecology. andrology. obstetrics (15) 15
major clinical study (15) 15
young adult (15) 15
breast neoplasms - pathology (14) 14
clinical trials (14) 14
research article (14) 14
cancer therapies (13) 13
carboplatin (13) 13
drug administration schedule (13) 13
medical prognosis (13) 13
metastasis (13) 13
oncology, experimental (13) 13
retrospective studies (13) 13
analysis (12) 12
breast neoplasms - genetics (12) 12
cancer survival (12) 12
clinical trial (12) 12
epirubicin (12) 12
ovarian neoplasms - drug therapy (12) 12
survival (12) 12
anemia (11) 11
breast neoplasms - mortality (11) 11
carboplatin - administration & dosage (11) 11
greece (11) 11
immunohistochemistry (11) 11
medicine & public health (11) 11
metastases (11) 11
neutropenia (11) 11
oxaliplatin (11) 11
antineoplastic agents - therapeutic use (10) 10
care and treatment (10) 10
colorectal neoplasms - drug therapy (10) 10
dose-response relationship, drug (10) 10
drug therapy (10) 10
fluorouracil - administration & dosage (10) 10
health aspects (10) 10
kaplan-meier estimate (10) 10
medical research (10) 10
ovarian neoplasms - pathology (10) 10
risk factors (10) 10
science (10) 10
cancer research (9) 9
cisplatin (9) 9
hematology, oncology and palliative medicine (9) 9
hospitals (9) 9
irinotecan (9) 9
mammary gland diseases (9) 9
multidisciplinary sciences (9) 9
prospective studies (9) 9
science & technology - other topics (9) 9
skin and connective tissue diseases (9) 9
advanced cancer (8) 8
alopecia (8) 8
apoptosis (8) 8
biomarkers (8) 8
breast neoplasms (8) 8
cancer chemotherapy (8) 8
cyclophosphamide (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Bevacizumab in combination with chemotherapy for the treatment of advanced ovarian cancer: A systematic review
by Aravantinos, Gerasimos and Pectasides, Dimitrios
Journal of ovarian research, ISSN 1757-2215, 05/2014, Volume 7, Issue 1, pp. 57 - 57
Targeted therapies | Angiogenesis | Primary peritoneal cancer | Fallopian tube cancer | Bevacizumab | Ovarian cancer | Life Sciences & Biomedicine | Reproductive Biology | Science & Technology | Humans | Angiogenesis Inhibitors - pharmacology | Neovascularization, Pathologic - diet therapy | Molecular Targeted Therapy | Randomized Controlled Trials as Topic | Angiogenesis Inhibitors - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antibodies, Monoclonal, Humanized - pharmacology | Female | Ovarian Neoplasms - blood supply | Ovarian Neoplasms - drug therapy | Oncology, Experimental | Research | Cancer | Studies | Chemotherapy | Womens health | Vascular endothelial growth factor | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
by Burtness, Barbara and Harrington, Kevin J and Greil, Richard and Soulières, Denis and Tahara, Makoto and de Castro, Gilberto and Psyrri, Amanda and Basté, Neus and Neupane, Prakash and Bratland, Åse and Fuereder, Thorsten and Hughes, Brett G M and Mesía, Ricard and Ngamphaiboon, Nuttapong and Rordorf, Tamara and Wan Ishak, Wan Zamaniah and Hong, Ruey-Long and González Mendoza, René and Roy, Ananya and Zhang, Yayan and Gumuscu, Burak and Cheng, Jonathan D and Jin, Fan and Rischin, Danny and Lerzo, Guillermo and Tatangelo, Marcelo and Varela, Mirta and Zarba, Juan Jose and Boyer, Michael and Gan, Hui and Gao, Bo and Hughes, Brett and Mallesara, Girish and Rischin, Danny and Taylor, Anne and Burian, Martin and Fuereder, Thorsten and Greil, Richard and Barrios, Carlos Henrique and de Castro Junior, Dalvaro Oliveira and Castro, Gilberto and Franke, Fabio Andre and Girotto, Gustavo and Lima, Iane Pinto Figueiredo and Nicolau, Ulisses Ribaldo and Pinto, Gustavo Dix Junqueira and Santos, Lucas and Victorino, Ana-Paula and Chua, Neil and Couture, Felix and Gregg, Richard and Hansen, Aaron and Hilton, John and McCarthy, Joy and Soulieres, Denis and Ascui, Rodrigo and Gonzalez, Pablo and Villanueva, Luis and Torregroza, Marco and Zambrano, Angela and Holeckova, Petra and Kral, Zdenek and Melichar, Bohuslav and Prausova, Jana and Vosmik, Milan and Andersen, Maria and Gyldenkerne, Niels and Jurgens, Hannes and Putnik, Kadri and Reinikainen, Petri and Gruenwald, Viktor and Laban, Simon and Aravantinos, Gerasimos and Boukovinas, Ioannis and Georgoulias, Vassilis and Psyrri, Amanda and Kwong, Dora and Al-Farhat, Yousuf and Csoszi, Tibor and Erfan, Jozsef and Horvai, Geza and Landherr, Laszlo and Remenar, Eva and Ruzsa, Agnes and Szota, Judit and Billan, Salem and Gluck, Iris and Gutfeld, Orit and Popovtzer, Aron and Benasso, Marco and Bui, Simona and Ferrari, Vittorio and Licitra, Lisa and Nole, Franco and Fujii, Takashi and Fujimoto, Yasushi and Hanai, Nobuhiro and Hara, Hiroki and Matsumoto, Koji and Mitsugi, Kenji and ... and KEYNOTE-048 Investigators
The Lancet (British edition), ISSN 0140-6736, 11/2019, Volume 394, Issue 10212, pp. 1915 - 1928
Humans | Middle Aged | Antibodies, Monoclonal, Humanized/therapeutic use | Antimetabolites, Antineoplastic/therapeutic use | Male | Antineoplastic Combined Chemotherapy Protocols/therapeutic use | Fluorouracil/therapeutic use | Progression-Free Survival | Cetuximab/therapeutic use | Antineoplastic Agents, Immunological/therapeutic use | Squamous Cell Carcinoma of Head and Neck/drug therapy | Female | Aged | Head and Neck Neoplasms/drug therapy | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antibodies, Monoclonal, Humanized - therapeutic use | Head and Neck Neoplasms - drug therapy | Squamous Cell Carcinoma of Head and Neck - mortality | Cetuximab - therapeutic use | Fluorouracil - therapeutic use | Antimetabolites, Antineoplastic - therapeutic use | Antineoplastic Agents, Immunological - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Squamous Cell Carcinoma of Head and Neck - drug therapy | Head and Neck Neoplasms - mortality | Squamous cell carcinoma | Chemotherapy | Metastasis | Analysis | Cancer | Medical research | 5-Fluorouracil | Mortality | Oncology | Survival | Metastases | Population (statistical) | Pembrolizumab | Hypotheses | Randomization | Platinum | Cell death | PD-L1 protein | Population | Head and neck cancer | Ligands | Larynx | Safety | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Immune-related dermatologic toxicities: to make a long story short
by Angelaki, Ariadni and Lampropoulou, Dimitra Ioanna and Aravantinos, Gerasimos
Cutaneous and ocular toxicology, ISSN 1556-9527, 01/2020, Volume 39, Issue 1, pp. 10 - 12
anti-PD-1/PD-L1 | Immune checkpoint inhibitors | anti-CTLA-4 | skin toxicity | immune-related adverse events | Toxicology | Ophthalmology | Life Sciences & Biomedicine | Science & Technology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text The combination of bevacizumab/temsirolimus after first-line anti-VEGF therapy in advanced renal-cell carcinoma: a clinical and biomarker study
by Bamias, Aristotelis and Bamias, Aristotelis and Karavasilis, Vasilios and Karavasilis, Vasilios and Gavalas, Nikolaos and Gavalas, Nikolaos and Tzannis, Kimon and Tzannis, Kimon and Samantas, Epaminontas and Samantas, Epaminontas and Aravantinos, Gerasimos and Aravantinos, Gerasimos and Koutras, Angelos and Koutras, Angelos and Gkerzelis, Ioannis and Gkerzelis, Ioannis and Kostouros, Euthymios and Kostouros, Euthymios and Koutsoukos, Konstantinos and Koutsoukos, Konstantinos and Zagouri, Flora and Zagouri, Flora and Fountzilas, George and Fountzilas, George and Dimopoulos, Meletios-Athanasios and Dimopoulos, Meletios-Athanasios
International journal of clinical oncology, ISSN 1341-9625, 4/2019, Volume 24, Issue 4, pp. 411 - 419
Medicine & Public Health | Renal cancer | FGF | Second-line, temsirolimus | Oncology | Cancer Research | Metastatic | Surgical Oncology | Bevacizumab | Life Sciences & Biomedicine | Science & Technology | Antimitotic agents | Carcinoma | Plants | Metastasis | Antineoplastic agents | Growth factors | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text First Line Gemcitabine/Pazopanib in Locally Advanced and/or Metastatic Biliary Tract Carcinoma. A Hellenic Cooperative Oncology Group Phase II Study
by Sgouros, Joseph and Aravantinos, Gerasimos and Koliou, Georgia-Angeliki and Pentheroudakis, George and Zagouri, Flora and Psyrri, Amanda and Lampropoulou, Dimitra Ioanna and Demiri, Stamatina and Pectasides, Dimitrios and Razis, Evangelia and Fountzilas, George and Samantas, Epaminontas
Anticancer research, ISSN 0250-7005, 02/2020, Volume 40, Issue 2, pp. 929 - 938
Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | Middle Aged | Deoxycytidine - pharmacology | Male | Treatment Outcome | Pyrimidines - pharmacology | Sulfonamides - pharmacology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Deoxycytidine - therapeutic use | Neoplasm Metastasis | Sulfonamides - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrimidines - therapeutic use | Aged, 80 and over | Female | Aged | Deoxycytidine - analogs & derivatives | Bile Duct Neoplasms - drug therapy | Biliary tract | Chemotherapy | Metastasis | Gemcitabine | Response rates | Metastases | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Recurrence-free Survival and Safety of Imatinib in Patients With Gastrointestinal Stromal Tumour (GIST) in Greece
by Boukovinas, Ioannis and Kotsakis, Athanasios and Androulakis, Nikolaos and Aravantinos, Gerasimos and Michalaki, Vasiliki and Christodoulou, Christos and Avgerinos, Antonios and Papandreou, Christos and Sidiropoulou, Vasiliki and Kousidou, Olga and Kosmidis, Paris
Anticancer research, ISSN 0250-7005, 01/2020, Volume 40, Issue 1, pp. 435 - 441
Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Greece | Neoplasm Recurrence, Local - pathology | Disease-Free Survival | Imatinib Mesylate - therapeutic use | DNA Mutational Analysis | Gastrointestinal Stromal Tumors - drug therapy | Imatinib Mesylate - adverse effects | Female | Imatinib | Mutation | Safety | Survival | Tumors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: A hellenic cooperative oncology group clinical translational study
by Briasoulis, Evangelos and Aravantinos, Gerasimos and Kouvatseas, George and Pappas, Periklis and Biziota, Eirini and Sainis, Ioannis and Makatsoris, Thomas and Varthalitis, Ioannis and Xanthakis, Ioannis and Vassias, Antonios and Klouvas, George and Boukovinas, Ioannis and Fountzilas, George and Syrigos, Kostantinos N and Kalofonos, Haralambos and Samantas, Epaminontas
BMC cancer, ISSN 1471-2407, 05/2013, Volume 13, Issue 1, pp. 263 - 263
Metronomic-chemotherapy | Antiangiogenic | Vinorelbine | Cancer | Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Prognosis | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Bone Neoplasms - secondary | Lung Neoplasms - pathology | Male | Vinblastine - administration & dosage | Liver Neoplasms - mortality | Dose-Response Relationship, Drug | Young Adult | Antineoplastic Agents, Phytogenic - administration & dosage | Vinblastine - analogs & derivatives | Biomarkers, Tumor - metabolism | Adult | Female | Bone Neoplasms - drug therapy | Liver Neoplasms - secondary | Real-Time Polymerase Chain Reaction | Prostatic Neoplasms - drug therapy | Carcinoma, Non-Small-Cell Lung - pathology | Prostatic Neoplasms - pathology | Enzyme-Linked Immunosorbent Assay | Time-to-Treatment | Administration, Oral | RNA, Messenger - genetics | Translational Medical Research | Liver Neoplasms - drug therapy | Survival Rate | Reverse Transcriptase Polymerase Chain Reaction | Breast Neoplasms - drug therapy | Carcinoma, Non-Small-Cell Lung - mortality | Prostatic Neoplasms - mortality | Breast Neoplasms - pathology | Adolescent | Breast Neoplasms - mortality | Aged | Biomarkers, Tumor - genetics | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Metastasis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text MiR-218 and miR-100 polymorphisms as markers of irinotecan-based chemotherapy response in metastatic colorectal cancer
by Lampropoulou, Dimitra-Ioanna and Aravantinos, Gerasimos and Laschos, Konstantinos and Theodosopoulos, Theodosis and Papadimitriou, Christos and Gazouli, Maria
International journal of colorectal disease, ISSN 0179-1958, 11/2019, Volume 34, Issue 11, pp. 1871 - 1877
Irinotecan | Single-nucleotide polymorphisms | Chemotherapy | Medicine & Public Health | miRNAs | mCRC | Surgery | Hepatology | Gastroenterology | Internal Medicine | Proctology | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Colorectal Neoplasms - genetics | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Irinotecan - therapeutic use | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Polymorphism, Single Nucleotide - genetics | Adult | Colorectal Neoplasms - secondary | Female | Aged | Biomarkers, Tumor - genetics | MicroRNAs - genetics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Caspase 8 and caspase 9 gene polymorphisms and susceptibility to gastric cancer
by Liamarkopoulos, Emmanouil and Gazouli, Maria and Aravantinos, Gerasimos and Tzanakis, Nikolaos and Theodoropoulos, George and Rizos, Spyros and Nikiteas, Nikolaos
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, ISSN 1436-3291, 10/2011, Volume 14, Issue 4, pp. 317 - 321
Caspase 9 | Gene polymorphisms | Caspase 8 | Medicine & Public Health | Gastroenterology | Abdominal Surgery | Oncology | Cancer Research | Surgical Oncology | Gastric cancer | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Caspase 8 - genetics | Stomach Neoplasms - genetics | Genetic Predisposition to Disease | Caspase 9 - genetics | Gene Frequency | Humans | Middle Aged | Female | Aged | Stomach Neoplasms - mortality | Case-Control Studies | Polymorphism, Genetic | Anopheles | Genes | Medical colleges | Genetic research | Genetic aspects | Disease susceptibility | Health aspects | Stomach cancer | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Management of Cancer-associated Thrombosis (CAT): Symptomatic or Incidental
by Papakotoulas, Pavlos and Tsoukalas, Nikolaos and Christopoulou, Athina and Ardavanis, Alexandros and Koumakis, Georgios and Papandreou, Christos and Papatsimpas, Georgios and Papakostas, Pavlos and Samelis, Georgios and Andreadis, Charalambos and Aravantinos, Gerasimos and Ziras, Nikolaos and Kalofonos, Charalambos and Samantas, Epameinondas and Souggleri, Maria and Makrantonakis, Paris and Pentheroudakis, Georgios and Athanasiadis, Athanasios and Stergiou, Helen and Tripodaki, Sofia and Bokas, Alexandros and Grivas, Anastasios and Timotheadou, Eleni and Bournakis, Evangelos and Varthalitis, Ioannis and Boukovinas, Ioannis
Anticancer research, ISSN 0250-7005, 01/2020, Volume 40, Issue 1, pp. 305 - 313
Life Sciences & Biomedicine | Oncology | Science & Technology | Neoplasm Recurrence, Local - pathology | Neoplasms - complications | Thrombosis - etiology | Hemorrhage - etiology | Humans | Middle Aged | Risk Factors | Female | Male | Thrombosis - therapy | Anticoagulants | Coagulation | Risk analysis | Thrombosis | Trauma | Bleeding | Risk factors | Molecular weight | Bevacizumab | Body mass index | Renal insufficiency | Body mass | Low molecular weights | Body size | Heparin | Thromboembolism | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy
by Fountzilas, George and Valavanis, Christos and Kotoula, Vassiliki and Eleftheraki, Anastasia G and Kalogeras, Konstantine T and Tzaida, Olympia and Batistatou, Anna and Kronenwett, Ralf and Wirtz, Ralph M and Bobos, Mattheos and Timotheadou, Eleni and Soupos, Nikolaos and Pentheroudakis, George and Gogas, Helen and Vlachodimitropoulos, Dimitrios and Polychronidou, Genovefa and Aravantinos, Gerasimos and Koutras, Angelos and Christodoulou, Christos and Pectasides, Dimitrios and Arapantoni, Petroula
Journal of translational medicine, ISSN 1479-5876, 01/2012, Volume 10, Issue 1, pp. 10 - 10
Mrna expression | Anthracyclines | Gene amplification | Top2a | Randomized study | Cish | Early breast cancer | Taxanes | Her2 | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Multivariate Analysis | Receptors, Estrogen - metabolism | Antibiotics, Antineoplastic - pharmacology | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Ki-67 Antigen - metabolism | Gene Expression Profiling | RNA, Messenger - metabolism | Receptors, Progesterone - metabolism | DNA-Binding Proteins - metabolism | Dose-Response Relationship, Drug | Paraffin Embedding | Young Adult | Poly-ADP-Ribose Binding Proteins | Breast Neoplasms - enzymology | Antigens, Neoplasm - metabolism | Adult | Female | Chemotherapy, Adjuvant | Gene Expression Regulation, Neoplastic - drug effects | Tissue Fixation | Genes, Neoplasm - genetics | Antigens, Neoplasm - genetics | DNA Topoisomerases, Type II - metabolism | RNA, Messenger - genetics | Risk Factors | Proportional Hazards Models | Treatment Outcome | DNA-Binding Proteins - genetics | Breast Neoplasms - drug therapy | Breast Neoplasms - genetics | Antibiotics, Antineoplastic - therapeutic use | Breast Neoplasms - pathology | Epirubicin - therapeutic use | DNA Topoisomerases, Type II - genetics | Aged | Epirubicin - pharmacology | Genes | Physiological aspects | Breast cancer | Genetic aspects | Research | Epirubicin | Drug therapy | Health aspects | DNA topoisomerase II | Medical research | Oncology | Cytotoxicity | Cancer therapies | Manuscripts | Medicine | Pathology | Chemotherapy | Hospitals | Writing | Drug dosages | Tumors | Index Medicus | TOP2A | early breast cancer | CISH | taxanes | anthracyclines | HER2 | gene amplification | randomized study | mRNA expression
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights